AMP Therapeutics - Anti-Microbial Peptide - Ownership and Business Overview

Life ScienceCompany

AMP Therapeutics - Anti-Microbial Peptide Ownership

Who owns AMP Therapeutics - Anti-Microbial Peptide?

AMP Therapeutics - Anti-Microbial Peptide is owned by EnBiotix. It was acquired on November 3, 2016.

AMP Therapeutics - Anti-Microbial Peptide Business Overview

Where is AMP Therapeutics - Anti-Microbial Peptide headquartered?

AMP Therapeutics - Anti-Microbial Peptide is headquartered in Leipzig, Germany.

What sector is AMP Therapeutics - Anti-Microbial Peptide in?

AMP Therapeutics - Anti-Microbial Peptide is a life science company.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 293 acquisitions of life science companies in 2016, including 32 acquisitions by private equity firms, and 261 by strategics.

AMP Therapeutics GmbH - Anti-Microbial Peptide

Leipzig, 04103
Germany,

AMP Therapeutics GmbH - Anti-Microbial Peptide comprises the first line of defense against infection through the innate immune system. The AMPT portfolio of unique antimicrobial peptides overcomes many of the issues associated with AMPs as anti-bacterial therapeutics, most notably potency, spectrum, stability and toxicity. The unique mechanism of action of these compounds and the low rate of resistance development positions these molecules as the next generation of novel anti-bacterials.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for AMP Therapeutics - Anti-Microbial Peptide

Life Science Companies , Germany Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Germany Companies

Largest Germany Companies , Acquisitive Germany Companies , Recently Acquired Germany Companies , Recently Sold Germany Companies , Private Germany Companies , Public Germany Companies , Acquired Germany Companies , PE Backed Germany Companies
Mergr

Product

Company

Legal